Literature DB >> 20647403

An evidence-based microsimulation model for colorectal cancer: validation and application.

Carolyn M Rutter1, James E Savarino.   

Abstract

BACKGROUND: The Colorectal Cancer Simulated Population model for Incidence and Natural history (CRC-SPIN) is a new microsimulation model for the natural history of colorectal cancer that can be used for comparative effectiveness studies of colorectal cancer screening modalities.
METHODS: CRC-SPIN simulates individual event histories associated with colorectal cancer, based on the adenoma-carcinoma sequence: adenoma initiation and growth, development of preclinical invasive colorectal cancer, development of clinically detectable colorectal cancer, death from colorectal cancer, and death from other causes. We present the CRC-SPIN structure and parameters, data used for model calibration, and model validation. We also provide basic model outputs to further describe CRC-SPIN, including annual transition probabilities between various disease states and dwell times. We conclude with a simple application that predicts the impact of a one-time colonoscopy at age 50 on the incidence of colorectal cancer assuming three different operating characteristics for colonoscopy.
RESULTS: CRC-SPIN provides good prediction of both the calibration and the validation data. Using CRC-SPIN, we predict that a one-time colonoscopy greatly reduces colorectal cancer incidence over the subsequent 35 years.
CONCLUSIONS: CRC-SPIN is a valuable new tool for combining expert opinion with observational and experimental results to predict the comparative effectiveness of alternative colorectal cancer screening modalities. IMPACT: Microsimulation models such as CRC-SPIN can serve as a bridge between screening and treatment studies and health policy decisions by predicting the comparative effectiveness of different interventions. As such, it is critical to publish model descriptions that provide insight into underlying assumptions along with validation studies showing model performance. (c)2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20647403      PMCID: PMC2919657          DOI: 10.1158/1055-9965.EPI-09-0954

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  30 in total

1.  Endoscopic perforation of the colon: lessons from a 10-year study.

Authors:  M L Anderson; T M Pasha; J A Leighton
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

Review 2.  The advanced adenoma as the primary target of screening.

Authors:  Sidney J Winawer; Ann G Zauber
Journal:  Gastrointest Endosc Clin N Am       Date:  2002-01

3.  Trends in screening for colorectal cancer--United States, 1997 and 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-03-09       Impact factor: 17.586

4.  The rate of adenocarcinoma in endoscopically removed colorectal polyps.

Authors:  Stephen R Odom; Stephen D Duffy; James E Barone; Vishal Ghevariya; Steven J McClane
Journal:  Am Surg       Date:  2005-12       Impact factor: 0.688

5.  Association of colonoscopy and death from colorectal cancer.

Authors:  Nancy N Baxter; Meredith A Goldwasser; Lawrence F Paszat; Refik Saskin; David R Urbach; Linda Rabeneck
Journal:  Ann Intern Med       Date:  2008-12-15       Impact factor: 25.391

Review 6.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

7.  Cost-effectiveness of colorectal cancer screening with computed tomography colonography: the impact of not reporting diminutive lesions.

Authors:  Perry J Pickhardt; Cesare Hassan; Andrea Laghi; Angelo Zullo; David H Kim; Sergio Morini
Journal:  Cancer       Date:  2007-06-01       Impact factor: 6.860

8.  Are endoscopic measurements of colonic polyps reliable?

Authors:  M B Fennerty; J Davidson; S S Emerson; R E Sampliner; L J Hixson; H S Garewal
Journal:  Am J Gastroenterol       Date:  1993-04       Impact factor: 10.864

9.  Five-year risk of colorectal neoplasia after negative screening colonoscopy.

Authors:  Thomas F Imperiale; Elizabeth A Glowinski; Ching Lin-Cooper; Gregory N Larkin; James D Rogge; David F Ransohoff
Journal:  N Engl J Med       Date:  2008-09-18       Impact factor: 91.245

Review 10.  The colorectal adenoma-carcinoma sequence.

Authors:  A Leslie; F A Carey; N R Pratt; R J C Steele
Journal:  Br J Surg       Date:  2002-07       Impact factor: 6.939

View more
  22 in total

1.  Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.

Authors:  Iris Lansdorp-Vogelaar; Roman Gulati; Angela B Mariotto; Clyde B Schechter; Tiago M de Carvalho; Amy B Knudsen; Nicolien T van Ravesteyn; Eveline A M Heijnsdijk; Chester Pabiniak; Marjolein van Ballegooijen; Carolyn M Rutter; Karen M Kuntz; Eric J Feuer; Ruth Etzioni; Harry J de Koning; Ann G Zauber; Jeanne S Mandelblatt
Journal:  Ann Intern Med       Date:  2014-07-15       Impact factor: 25.391

2.  Clarifying differences in natural history between models of screening: the case of colorectal cancer.

Authors:  Marjolein van Ballegooijen; Carolyn M Rutter; Amy B Knudsen; Ann G Zauber; James E Savarino; Iris Lansdorp-Vogelaar; Rob Boer; Eric J Feuer; J Dik F Habbema; Karen M Kuntz
Journal:  Med Decis Making       Date:  2011-06-14       Impact factor: 2.583

3.  Bayesian Methods for Calibrating Health Policy Models: A Tutorial.

Authors:  Nicolas A Menzies; Djøra I Soeteman; Ankur Pandya; Jane J Kim
Journal:  Pharmacoeconomics       Date:  2017-06       Impact factor: 4.981

4.  Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves.

Authors:  Ankur Pandya; Stephen Sy; Sylvia Cho; Sartaj Alam; Milton C Weinstein; Thomas A Gaziano
Journal:  Med Decis Making       Date:  2017-05-10       Impact factor: 2.583

5.  What is the optimal colorectal cancer screening program for an average-risk population?

Authors:  Masau Sekiguchi; Takahisa Matsuda; Yutaka Saito
Journal:  Transl Gastroenterol Hepatol       Date:  2017-03-16

Review 6.  Microsimulation Modeling in Oncology.

Authors:  Çağlar Çağlayan; Hiromi Terawaki; Qiushi Chen; Ashish Rai; Turgay Ayer; Christopher R Flowers
Journal:  JCO Clin Cancer Inform       Date:  2018-12

7.  A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling.

Authors:  Fernando Alarid-Escudero; Eline M Krijkamp; Petros Pechlivanoglou; Hawre Jalal; Szu-Yu Zoe Kao; Alan Yang; Eva A Enns
Journal:  Pharmacoeconomics       Date:  2019-11       Impact factor: 4.981

8.  Validation of Models Used to Inform Colorectal Cancer Screening Guidelines: Accuracy and Implications.

Authors:  Carolyn M Rutter; Amy B Knudsen; Tracey L Marsh; V Paul Doria-Rose; Eric Johnson; Chester Pabiniak; Karen M Kuntz; Marjolein van Ballegooijen; Ann G Zauber; Iris Lansdorp-Vogelaar
Journal:  Med Decis Making       Date:  2016-01-08       Impact factor: 2.583

9.  Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.

Authors:  Carolyn M Rutter; Jane J Kim; Reinier G S Meester; Brian L Sprague; Emily A Burger; Ann G Zauber; Mehmet Ali Ergun; Nicole G Campos; Chyke A Doubeni; Amy Trentham-Dietz; Stephen Sy; Oguzhan Alagoz; Natasha Stout; Iris Lansdorp-Vogelaar; Douglas A Corley; Anna N A Tosteson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-17       Impact factor: 4.254

10.  Cancer Models and Real-world Data: Better Together.

Authors:  Jane J Kim; Anna Na Tosteson; Ann G Zauber; Brian L Sprague; Natasha K Stout; Oguzhan Alagoz; Amy Trentham-Dietz; Katrina Armstrong; Sandi L Pruitt; Carolyn M Rutter
Journal:  J Natl Cancer Inst       Date:  2015-11-03       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.